Branched-chain amino acid (BCAA) metabolism is dysregulated in colorectal cancer (CRC), with elevated plasma BCAA levels significantly associated with an increased risk of developing the disease.
However, whether BCAAs directly promote CRC progression and their underlying mechanisms remain unclear.
